ROZEFIT LTD

Company number 14603168 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

ROZEFIT LTD - Analysis Report

Company Number: 14603168

Analysis Date: 2025-07-29 13:31 UTC

Financial Health Assessment for ROZEFIT LTD


1. Financial Health Score: D (Early Stage - Insufficient Data)

Explanation:
ROZEFIT LTD is a very young company, incorporated in January 2023, with its first and only set of micro-entity accounts filed for the year ending January 31, 2024. The financial statements show a flat balance sheet with zero net assets, zero liabilities, and minimal shareholder funds (£1 share capital). This score reflects the early startup status rather than financial distress. However, due to lack of operational financial data such as revenues, profits, cash flows, or working capital, a robust health assessment is constrained. The absence of liabilities and assets suggests minimal financial activity to date.


2. Key Vital Signs

Metric Value Interpretation
Company Age ~1 year Company is very new, likely in initial setup or early development phase
Account Category Micro Minimal filing requirements, indicating small scale operations
Share Capital £1.00 Nominal capital, common for startups; low equity base
Net Current Assets £0 No working capital surplus or deficit; no short-term liquidity buffer evident
Current Liabilities £0 No short-term debts or payables recorded
Net Assets £0 Total assets equal total liabilities; no retained earnings or accumulated reserves
Number of Employees 1 Very lean operation, possibly just the director or owner
Directors and PSCs Multiple changes Several director turnovers within first year, may indicate management adjustments or instability
SIC Code 47990 (Other retail sale not in stores) Reflects online or non-traditional retail business model
Filing Status Up to date No overdue accounts or confirmation statements; compliant filing

Interpretation:
The financial vital signs are akin to a patient in the neonatal stage. The company has yet to develop measurable financial "muscle" or a cash flow "pulse." The zero net assets and liabilities indicate no financial stress but also no significant business activity or capital investment. The single employee and multiple director changes suggest a startup in formation or transition.


3. Diagnosis

ROZEFIT LTD is in its infancy, with no recorded financial transactions beyond the initial setup capital. This "financial blank slate" means there is no current symptom of distress such as debt overload, poor liquidity, or negative equity. However, there is also no evidence of revenue generation, profitability, or asset accumulation. The changing director profile could be a natural evolution in early governance but might also signal some internal uncertainty. The business operates in a retail sector not tied to physical stores, which usually requires effective digital marketing and supply chain setup to gain traction.

In medical terms, the company is a newborn with stable vital signs but untested resilience. The key concern is to monitor growth indicators as the company begins operations, ensuring it develops healthy cash flow and capital structure to avoid future financial ailments.


4. Recommendations

  • Build Financial Activity: Initiate revenue-generating operations and record sales, expenses, and cash flow promptly to develop a clear financial picture.
  • Cash Flow Management: Establish a cash flow forecast to ensure the company maintains liquidity and can meet obligations as it grows.
  • Capital Injection: Consider increasing equity or securing startup financing to build working capital and invest in business development.
  • Governance Stability: Aim for stable and consistent management to provide strategic direction and reduce uncertainty among stakeholders.
  • Regular Financial Review: Implement monthly financial reviews to detect early symptoms of financial stress such as rising costs or delayed payments.
  • Compliance Vigilance: Maintain timely filing of accounts and confirmation statements to avoid penalties and build credibility.
  • Business Plan Refinement: Clarify market approach, pricing, and cost structure to ensure the business model is viable and scalable.

Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 29 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.